Reproductive Health
News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.
The genetic testing and health intelligence firm will start trading on the Nasdaq Global Select Market on Friday under the ticker symbols SMFR and SMFRW.
ACMG Updates Carrier Screening Recommendations for Autosomal Recessive, X-Linked Conditions
The updated ACMG guidelines on carrier screening recommended a consistent and more equitable approach to testing.
InfanDx, Cash in Hand, Moves Closer to Launching Dx to ID Potential Brain Damage in Newborns
Premium
The Cologne, Germany-based company this week raised €4 million ($4.7 million) in a Series A financing round and plans to use the funds for developing its first test.
Sera Prognostics Goes Public With $75M IPO
The firm is offering 4,687,500 shares of its common stock at $16 per share. Its first commercial product is the PreTRM test for predicting the risk of a preterm birth.
Natera Inks Distribution Deal With TomaLab for Italy
The deal covers three of Natera's tests including its Signatera circulating tumor DNA test for cancer treatment monitoring and minimal residual disease assessment.